Related Experiment Video
Updated: Jun 23, 2026
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Pediatric seizure and epilepsy classification: why is it important or is it important?
Matthew Troester1, Harold L Rekate
1Barrow Neurologic Institute, University of Arizona, College of Medicine, Phoenix, AZ 85013, USA.
Seminars in Pediatric Neurology
|May 5, 2009
Summary
Classifying pediatric epilepsy, especially in neonates, presents unique challenges. This review analyzes existing and proposed pediatric seizure and epilepsy classifications for clinical utility.
Area of Science:
- Neurology
- Pediatrics
- Epileptology
Background:
- Epilepsy and seizure classification is a complex and debated topic.
- Pediatric seizure and epilepsy classification, particularly in neonates, differs significantly from adult classifications.
- Existing frameworks like the 1981 and 1989 International League Against Epilepsy classifications have limitations for pediatric use.
Purpose of the Study:
- To review and analyze existing seizure and epilepsy classification systems.
- To specifically examine pediatric-specific classification components.
- To assess the applicability and utility of these classifications for pediatric healthcare providers and researchers.
Main Methods:
- Literature review of seizure and epilepsy classification systems.
- Analysis of pediatric-specific modifications and proposed schemes.
- Evaluation of classifications based on clinical applicability and utility for pediatric physician-scientists.
Main Results:
- The 1981 and 1989 International League Against Epilepsy classifications are foundational but not universally accepted for pediatrics.
- Several pediatric-specific classifications have been proposed, with a focus on the neonatal population.
- The utility and applicability of these pediatric classifications vary.
Conclusions:
- There is a need for universally accepted, pediatric-specific seizure and epilepsy classification systems.
- Further research is required to refine and validate classifications for the neonatal and pediatric populations.
- Improved classification aids in diagnosis, treatment, and research in pediatric epilepsy.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
07:35Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Related Concept Videos
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...